Pharma News

Keep updating your pharma knowledge
24 Jun 2019

What is CRL – Complete Response Letter by USFDA?

Posted By

Complete response letter is issued by USFDA to new drug / abbreviated application holder, if they determines that we will not approve the application or abbreviated application in its present form for one or more of the reasons.

CRL contains

  • Description of specific deficiencies.
  • Complete review of data.
  • In case of Inadequate data, they highlights inadequacy.
  • They also mention recommended action for approval.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!